KVK Captan 83

Primær information

  • Handelsnavn:
  • KVK Captan 83 Pulver
  • Lægemiddelform:
  • Pulver
  • Sammensætning:
  • 830 g/kg captan
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • KVK Captan 83 Pulver
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • 16-5
  • Sidste ændring:
  • 08-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

10-4-2018

System 83 Plus Automated Endoscope Reprocessors (AERs) by Custom Ultrasonics: FDA Safety Communication - Completed Validation Testing

System 83 Plus Automated Endoscope Reprocessors (AERs) by Custom Ultrasonics: FDA Safety Communication - Completed Validation Testing

System 83 Plus AERs may now be used to reprocess only the Olympus TJF-Q180V duodenoscope and the Pentax ED-3490TK duodenoscope.

FDA - U.S. Food and Drug Administration

14-8-2017

Scientific guideline:  Guideline on manufacture of the finished dosage form, adopted

Scientific guideline: Guideline on manufacture of the finished dosage form, adopted

This guideline replaces the note for guidance on the manufacture of the finished dosage form (CPMP/QWP/486/95). The note for guidance has been updated to reflect the requirements as laid down in the current legislation Directive 2001/83/EC, and to follow the format and content of the Common Technical Document (CTD) Module 3 dossier. It also addresses current manufacturing practices in terms of complex supply chains and worldwide manufacture. In addition, the content and principles of the ICH Q8 guideline...

Europe - EFSA - European Food Safety Authority EFSA Journal

14-8-2017

Scientific guideline:  Guideline on manufacture of the finished dosage form - Revision 1, adopted

Scientific guideline: Guideline on manufacture of the finished dosage form - Revision 1, adopted

This guideline replaces the note for guidance on the manufacture of the finished dosage form (CPMP/QWP/486/95). The note for guidance has been updated to reflect the requirements as laid down in the current legislation Directive 2001/83/EC, and to follow the format and content of the Common Technical Document (CTD) Module 3 dossier. It also addresses current manufacturing practices in terms of complex supply chains and worldwide manufacture. In addition, the content and principles of the ICH Q8 guideline...

Europe - EFSA - European Food Safety Authority EFSA Journal

16-6-2017

 Eleven new substances on the list of euphoriant substances

Eleven new substances on the list of euphoriant substances

On 15 June 2017, 11 new substances were included in annex 1 of executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health. The information is primarily relevant to companies authorised to deal with euphoriant substances. As from 15 June 2017, the following substances are included in schedule B: 0. AB-CHMINACA (N-(1-aminocarbonyl-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamid). 15 b. AMB-FUBINACA (N-(1-methoxycarbonyl-2-methylpropyl)-1-(...

Danish Medicines Agency

3-10-2014

Consultation procedure about medicinal products and safety measure requirements not completed yet

Consultation procedure about medicinal products and safety measure requirements not completed yet

On 5 September 2014, the Danish Health and Medicines Authority submitted a draft list of the medicinal products comprised by the new safety measures rules (Directive 2001/83) for consultation. The consultation period expired on 17 September 2014, and on 3 October we were to inform the European Commission of the medicinal products we recommend including in the common EU lists. We have received 22 consultation responses. But on 24 September 2014 the European Commission amended the original guideline for...

Danish Medicines Agency

29-1-2014

Information to MAHs for new combined hormonal contraceptives

Information to MAHs for new combined hormonal contraceptives

After the most recent EU review of a number of new combined contraceptives under Article 31 of Directive 2001/83/EC, it was decided that marketing authorisation holder (MAHs) for these products must send out DHPCs and guidance material to doctors.

Danish Medicines Agency

29-3-2018

PHENTERMINE HYDROCHLORIDE Tablet [KVK-TECH, Inc.]

PHENTERMINE HYDROCHLORIDE Tablet [KVK-TECH, Inc.]

Updated Date: Mar 29, 2018 EST

US - DailyMed

15-2-2018

OXYCODONE AND ACETAMINOPHEN Tablet [KVK-Tech, Inc.]

OXYCODONE AND ACETAMINOPHEN Tablet [KVK-Tech, Inc.]

Updated Date: Feb 15, 2018 EST

US - DailyMed

3-1-2018

OXYMORPHONE HYDROCHLORIDE Tablet [KVK-Tech, Inc.]

OXYMORPHONE HYDROCHLORIDE Tablet [KVK-Tech, Inc.]

Updated Date: Jan 3, 2018 EST

US - DailyMed

3-1-2018

OXYBUTYNIN CHLORIDE Tablet [KVK-Tech, Inc.]

OXYBUTYNIN CHLORIDE Tablet [KVK-Tech, Inc.]

Updated Date: Jan 3, 2018 EST

US - DailyMed

27-12-2017

OXYCODONE HYDROCHLORIDE Capsule [KVK-TECH, INC.]

OXYCODONE HYDROCHLORIDE Capsule [KVK-TECH, INC.]

Updated Date: Dec 27, 2017 EST

US - DailyMed

27-12-2017

OXYCODONE HYDROCHLORIDE Tablet [KVK-TECH,INC]

OXYCODONE HYDROCHLORIDE Tablet [KVK-TECH,INC]

Updated Date: Dec 27, 2017 EST

US - DailyMed

26-12-2017

PHENDIMETRAZINE TARTRATE Tablet [KVK-TECH, INC]

PHENDIMETRAZINE TARTRATE Tablet [KVK-TECH, INC]

Updated Date: Dec 26, 2017 EST

US - DailyMed

26-12-2017

PROMETHAZINE HYDROCHLORIDE Tablet [KVK-Tech, Inc.]

PROMETHAZINE HYDROCHLORIDE Tablet [KVK-Tech, Inc.]

Updated Date: Dec 26, 2017 EST

US - DailyMed

26-12-2017

SODIUM POLYSTYRENE SULFONATE Powder [KVK-Tech, Inc.]

SODIUM POLYSTYRENE SULFONATE Powder [KVK-Tech, Inc.]

Updated Date: Dec 26, 2017 EST

US - DailyMed

18-12-2017

METHYLPHENIDATE (Methylphenidate Hydrochloride) Solution [KVK-Tech, Inc.]

METHYLPHENIDATE (Methylphenidate Hydrochloride) Solution [KVK-Tech, Inc.]

Updated Date: Dec 18, 2017 EST

US - DailyMed

18-12-2017

METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE Tablet [KVK-Tech, Inc.]

METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE Tablet [KVK-Tech, Inc.]

Updated Date: Dec 18, 2017 EST

US - DailyMed

11-12-2017

INDOMETHACIN Capsule, Extended Release [KVK-Tech, Inc.]

INDOMETHACIN Capsule, Extended Release [KVK-Tech, Inc.]

Updated Date: Dec 11, 2017 EST

US - DailyMed

8-12-2017

DIETHYLPROPION HYDROCHLORIDE Tablet [KVK-TECH, INC]

DIETHYLPROPION HYDROCHLORIDE Tablet [KVK-TECH, INC]

Updated Date: Dec 8, 2017 EST

US - DailyMed

6-12-2017

DEXMETHYLPHENIDATE HYDROCHLORIDE Tablet [KVK-TECH, INC]

DEXMETHYLPHENIDATE HYDROCHLORIDE Tablet [KVK-TECH, INC]

Updated Date: Dec 6, 2017 EST

US - DailyMed

5-12-2017

BETAXOLOL HYDROCHLORIDE Tablet, Coated [KVK-TECH, INC.]

BETAXOLOL HYDROCHLORIDE Tablet, Coated [KVK-TECH, INC.]

Updated Date: Dec 5, 2017 EST

US - DailyMed

5-12-2017

CYCLOBENZAPRINE HYDROCHLORIDE Tablet, Film Coated [KVK-TECH, Inc.]

CYCLOBENZAPRINE HYDROCHLORIDE Tablet, Film Coated [KVK-TECH, Inc.]

Updated Date: Dec 5, 2017 EST

US - DailyMed

30-11-2017

BENZPHETAMINE HYDROCHLORIDE Tablet [KVK-TECH, INC]

BENZPHETAMINE HYDROCHLORIDE Tablet [KVK-TECH, INC]

Updated Date: Nov 30, 2017 EST

US - DailyMed

22-8-2017

Scientific guideline:  Draft guideline on non-clinical documentation in applications for marketing authorisation/registration of well-established and traditional herbal medicinal products - Revision 1, draft: consultation open

Scientific guideline: Draft guideline on non-clinical documentation in applications for marketing authorisation/registration of well-established and traditional herbal medicinal products - Revision 1, draft: consultation open

This guideline is intended to give advice for preparing and assessing applications for marketing authorisation of well-established herbal medicinal products and for the registration of traditional herbal medicinal products. It should be read in conjunction with the general requirements set out by Directive 2001/83/EC1, in particular its Annex I, and general methodological requirements published by the 29 EMA.

Europe - EMA - European Medicines Agency

17-8-2017

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Tablet [KVK-Tech, Inc.]

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Tablet [KVK-Tech, Inc.]

Updated Date: Aug 17, 2017 EST

US - DailyMed

31-7-2017

OXYCODONE HYDROCHLORIDE Solution OXYCODONE HYDROCHLORIDE Solution [KVK-Tech, Inc.]

OXYCODONE HYDROCHLORIDE Solution OXYCODONE HYDROCHLORIDE Solution [KVK-Tech, Inc.]

Updated Date: Jul 31, 2017 EST

US - DailyMed

5-7-2017

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablet [KVK-Tech, Inc.]

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablet [KVK-Tech, Inc.]

Updated Date: Jul 5, 2017 EST

US - DailyMed

29-6-2017

PHENTERMINE HYDROCHLORIDE Tablet PHENTERMINE HYDROCHLORIDE Capsule [KVK-TECH, Inc.]

PHENTERMINE HYDROCHLORIDE Tablet PHENTERMINE HYDROCHLORIDE Capsule [KVK-TECH, Inc.]

Updated Date: Jun 29, 2017 EST

US - DailyMed

16-6-2017

PHENTERMINE HYDROCHLORIDE Capsule [KVK-Tech, Inc.]

PHENTERMINE HYDROCHLORIDE Capsule [KVK-Tech, Inc.]

Updated Date: Jun 16, 2017 EST

US - DailyMed

24-5-2017

METHYLPHENIDATE HYDROCHLORIDE Tablet [KVK-TECH, INC.]

METHYLPHENIDATE HYDROCHLORIDE Tablet [KVK-TECH, INC.]

Updated Date: May 24, 2017 EST

US - DailyMed